EMvision Medical Devices (ASX: EMV) — Company Overview, News & Financial Data
EMvision Medical Devices is a medical technology company focused on the development and commercialisation of portable electromagnetic brain imaging devices for rapid stroke diagnosis and monitoring.
EMvision Medical Devices
EMvision Medical Devices is a medical technology company focused on the development and commercialisation of portable electromagnetic brain imaging devices for rapid stroke diagnosis and monitoring. The company's proprietary technology utilizes safe, non-ionising electromagnetic waves combined with artificial intelligence algorithms to distinguish between ischemic and haemorrhagic strokes at the point of care. Designed for bedside hospital use and pre-hospital emergency medical services, its neurodiagnostic scanners aim to accelerate critical clinical decision-making and treatment administration. EMvision conducts multi-site clinical trials across major hospitals and health networks to validate its diagnostic hardware and software platforms for emergency care.
Snapshot
Operations
Products and/or services of EMvision Medical Devices
- Bedside Brain Scanners: Mobile electromagnetic neurodiagnostic imaging systems engineered for point-of-care stroke classification in hospital emergency departments and intensive care units, providing rapid bedside diagnostic scans without requiring patient transport or specialized radiologic shielding infrastructure.
- Pre-Hospital Emergency Units: Ultra-lightweight electromagnetic brain scanners designed for integration into standard road and air ambulance fleets, enabling first responders to conduct rapid pre-hospital neurodiagnostic evaluations and triage patients prior to hospital arrival.
- Diagnostic Signal Algorithms: Artificial intelligence software integrated into proprietary hardware to analyze reflected electromagnetic waves, detect cerebral tissue changes, and classify ischemic versus hemorrhagic stroke types within minutes to assist clinical treatment decisions.
- Clinical Trial Validation: Multi-center clinical studies conducted across major Australian health networks to gather patient scan datasets, validate diagnostic accuracy against conventional computed tomography scans, and support global regulatory clearance submissions.
- Antenna Array Hardware: Flexible electromagnetic sensor headsets and multi-channel radiofrequency hardware engineered to emit low-power, non-ionizing electromagnetic signals safely across diverse patient head sizes without ionizing radiation or ferromagnetism risks.
- Digital Neurodiagnostics Infrastructure: Connected cloud and enterprise data architectures supporting secure scan transmission, automated algorithm processing, diagnostic image management, and seamless remote system integration with hospital electronic health record platforms.
EMvision Medical Devices executive team
- Mr. Scott KirklandCEO, MD & Executive Director
- Ms. Emma WaldonCFO & Company Secretary
- Ms. Forough KhandanChief Technology Officer
- Prof. Stuart Crozier B.E., M.Sc., Ph.D.Chairman of Clinical Advisory Board & Chief Scientific Officer
- Mr. Robert TillerHead of Design
- Dr. Konstanty BialkowskiHead of Tech Development
- Dr. Christian WightHead of Regulatory Affairs